Granola at the Year Mark: Still the Best Note-Taker for Executives?

Three years into our coverage of AI note-takers and 18 months into our specific tracking of Granola, the product has compounded into the structurally decisive answer for executive note-taking. The competitive landscape has clarified. The product velocity has held. The pricing has crept upward but the value defense remains strong. We tested the current product at the executive teams of three growth-stage companies during Q1 2026.

What's changed in the last 12 months

The executive briefing feature is the largest single improvement. The product now produces a daily briefing that aggregates across all meetings, surfaces patterns (which projects are stalling, which decisions are recurring), and identifies follow-ups. For chief-of-staff roles and executive-team leaders, this is the single most useful AI workflow we have tested in any productivity tool.

The integration ecosystem has matured. Granola now connects cleanly to Salesforce, HubSpot, Notion, Slack, Asana, and the broader productivity stack. The CRM integration in particular has improved to the point where Granola is now a credible answer for executive sales-team motion (though Fireflies remains the better answer for the rep-side workflow).

The local-first architecture continues to be the durable structural advantage. Each year we expect a competitor to match it; each year we are wrong. The architectural commitment is increasingly the kind of moat that compounds rather than erodes.

The product has compounded into the structurally decisive answer for executive note-taking. The gap to alternatives is wider than it was 12 months ago.

Where the case has limits

Pricing has crept upward to $20/seat at the Team tier and meaningfully higher at Business and Enterprise. For a 12-person executive team, the annual cost is now approximately $2,900. For organizations rolling Granola broader (full leadership team, including managers), the cost compounds. Buyers at scale should negotiate.

The product remains the wrong answer for sales-led conversation intelligence. Fireflies, Gong, and Chorus are the structurally serious answers for that use case. Granola's strengths are aimed at the executive workflow, not the sales-rep workflow.

The multi-language meeting weakness is the third remaining issue. We covered this in our 2026 re-test of the broader category; it persists. For organizations with European or Asia-Pacific executive teams, the meeting summaries from multi-lingual sessions still require manual review.

On the alternatives

We tested Otter, Fireflies, and Fathom alongside Granola. The case for Granola at the executive workflow is decisive against all three for the modal use case (small video calls, executive 1:1s, board prep, leadership offsites). Otter remains the right answer for hard-room and field-research. Fireflies remains the right answer for sales-led organizations consolidating into CRM. Fathom is the strongest free-tier option for individual users.

The broader category has matured to the point where the wrong choice is the choice nobody made deliberately. Granola is the right deliberate choice for executive workflows.

What to do

For new executive teams evaluating: Granola is the default answer. Pilot at 5-8 seats for 60 days; the executive briefing feature is the one to focus on in the evaluation.

For existing Granola customers at the Team or Business tier: renew but negotiate. The vendor's renewal posture has hardened slightly; buyers who push back are getting modest concessions on annual escalators.

For organizations evaluating across the full category: Granola plus a sales-side conversation intelligence tool (Gong or Fireflies for the sales team) is the pattern that produces the best operational outcome. Don't try to make a single product cover both the executive and sales workflows.

The verdict

Granola is the structurally decisive answer for executive note-taking in 2026. The case has gotten stronger, not weaker, over the last 12 months. The 4.7 reflects both the durable strength of the product and the increasing gap to alternatives. The pricing is the only meaningful negative; everything else is in the company's favor. We expect the case to remain decisive through 2026 and likely into 2027.